振動(dòng)正壓呼氣對(duì)慢阻肺急性加重患者排痰及肺功能的影響
發(fā)布時(shí)間:2019-01-03 07:12
【摘要】:目的:觀察振動(dòng)正壓呼氣對(duì)慢阻肺急性加重患者排痰、肺功能及臨床癥狀的影響方法:選擇2016年09月-2017年03月在我科治療的慢阻肺急性加重患者120例,其中男83例,女37例,年齡47-96歲,平均年齡71.85±9.02歲。所有患者均符合2016慢性阻塞性肺疾病全球倡議(GOLD指南)中慢性阻塞性肺疾病的診斷標(biāo)準(zhǔn),且符合其中對(duì)于急性加重的定義。將患者隨機(jī)分為對(duì)照組和治療組各60例,對(duì)照組予以止咳化痰、解痙平喘及抗感染等常規(guī)治療,治療組在對(duì)照組常規(guī)治療基礎(chǔ)上加用振動(dòng)正壓呼氣裝裝置治療一周。觀察1.兩組患者治療后1-7天痰的變化(痰量、痰液顏色、痰液粘稠度)2.兩組患者治療后肺功能的變化:第一秒用力呼氣容積(FEV1),第一秒用力呼氣容積占預(yù)計(jì)值的百分比(FEV1%pred)3.兩組患者治療后臨床癥狀評(píng)分的改變:慢性阻塞性肺疾病評(píng)估測(cè)試評(píng)分(CAT評(píng)分)、轉(zhuǎn)化呼吸困難指數(shù)評(píng)分(TDI評(píng)分)。結(jié)果:1.治療組患者第1-3天平均排痰量較對(duì)照組明顯增多(P0.05);治療組患者第3天痰色評(píng)分較對(duì)照組明顯低(P0.05);第3天痰液粘稠度較對(duì)照組下降顯著(P0.05)2.治療組第3天FEV1及FEV1%pred較對(duì)照組升高明顯,升高值比較有統(tǒng)計(jì)學(xué)意義(P0.05)3.第3天治療組CAT評(píng)分下降較對(duì)照組明顯,下降值比較有統(tǒng)計(jì)學(xué)意義(P0.05);第3天TDI評(píng)分治療組較對(duì)照組升高,升高值比較有統(tǒng)計(jì)學(xué)意義(P0.05)結(jié)論:1.振動(dòng)正壓呼氣治療法可有效促進(jìn)慢阻肺急性加重患者排痰2.振動(dòng)正壓呼氣治療法可改善慢阻肺急性加重患者肺功能3.振動(dòng)正壓呼氣治療法可改善慢阻肺急性加重患者臨床癥狀
[Abstract]:Objective: to observe the effect of positive vibration expiratory pressure on sputum excretion, pulmonary function and clinical symptoms in patients with acute exacerbation of COPD. Methods: 120 patients with acute exacerbation of COPD treated in our department from September 2016 to March 2017 were selected, including 83 males and 37 females. The average age was 71.85 鹵9.02 years. All patients met the diagnostic criteria of the 2016 Global Initiative for chronic obstructive Pulmonary Disease (GOLD) and the definition of acute exacerbation. The patients were randomly divided into control group (n = 60) and treatment group (n = 60). The control group was treated with routine treatment such as relieving cough and resolving phlegm, spasmolysis and anti-infection. The treatment group was treated with positive vibratory expiratory device for one week on the basis of routine treatment in the control group. Observation 1. The changes of sputum (sputum volume, sputum color, sputum viscosity) in both groups were 1-7 days after treatment. Changes in pulmonary function after treatment: forced expiratory volume in the first second (FEV1) and forced expiratory volume in the first second as a percentage of the predicted value (FEV1%pred). The changes of clinical symptom score after treatment: chronic obstructive pulmonary disease assessment test score (CAT), transforming dyspnea index score (TDI score). Results: 1. The average amount of sputum excretion in the treatment group was significantly higher than that in the control group on the 1-3 day (P0.05); the phlegm color score on the 3rd day in the treatment group was significantly lower than that in the control group (P0.05); the viscosity of sputum in the treatment group was significantly lower than that in the control group (P0.05) on the 3rd day (P0.05). FEV1 and FEV1%pred in the treatment group were significantly higher than those in the control group on day 3 (P0.05). On the 3rd day, the CAT score in the treatment group was significantly lower than that in the control group (P0.05), and the TDI score in the treatment group was higher than that in the control group on the 3rd day (P0.05). Conclusion: 1. Positive vibratory expiratory therapy can effectively promote sputum excretion in patients with acute exacerbation of COPD. Positive vibratory expiratory therapy can improve pulmonary function in patients with acute exacerbation of COPD. Positive vibratory expiratory therapy can improve clinical symptoms in patients with acute exacerbation of COPD
【學(xué)位授予單位】:揚(yáng)州大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:R563.9
[Abstract]:Objective: to observe the effect of positive vibration expiratory pressure on sputum excretion, pulmonary function and clinical symptoms in patients with acute exacerbation of COPD. Methods: 120 patients with acute exacerbation of COPD treated in our department from September 2016 to March 2017 were selected, including 83 males and 37 females. The average age was 71.85 鹵9.02 years. All patients met the diagnostic criteria of the 2016 Global Initiative for chronic obstructive Pulmonary Disease (GOLD) and the definition of acute exacerbation. The patients were randomly divided into control group (n = 60) and treatment group (n = 60). The control group was treated with routine treatment such as relieving cough and resolving phlegm, spasmolysis and anti-infection. The treatment group was treated with positive vibratory expiratory device for one week on the basis of routine treatment in the control group. Observation 1. The changes of sputum (sputum volume, sputum color, sputum viscosity) in both groups were 1-7 days after treatment. Changes in pulmonary function after treatment: forced expiratory volume in the first second (FEV1) and forced expiratory volume in the first second as a percentage of the predicted value (FEV1%pred). The changes of clinical symptom score after treatment: chronic obstructive pulmonary disease assessment test score (CAT), transforming dyspnea index score (TDI score). Results: 1. The average amount of sputum excretion in the treatment group was significantly higher than that in the control group on the 1-3 day (P0.05); the phlegm color score on the 3rd day in the treatment group was significantly lower than that in the control group (P0.05); the viscosity of sputum in the treatment group was significantly lower than that in the control group (P0.05) on the 3rd day (P0.05). FEV1 and FEV1%pred in the treatment group were significantly higher than those in the control group on day 3 (P0.05). On the 3rd day, the CAT score in the treatment group was significantly lower than that in the control group (P0.05), and the TDI score in the treatment group was higher than that in the control group on the 3rd day (P0.05). Conclusion: 1. Positive vibratory expiratory therapy can effectively promote sputum excretion in patients with acute exacerbation of COPD. Positive vibratory expiratory therapy can improve pulmonary function in patients with acute exacerbation of COPD. Positive vibratory expiratory therapy can improve clinical symptoms in patients with acute exacerbation of COPD
【學(xué)位授予單位】:揚(yáng)州大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:R563.9
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 崔建蓉;;中性粒細(xì)胞/淋巴細(xì)胞比值對(duì)老年AECOPD患者住院期間不良預(yù)后的影響[J];海南醫(yī)學(xué)院學(xué)報(bào);2016年02期
2 李杰;王琦;張立山;邱澤計(jì);吳s,
本文編號(hào):2399052
本文鏈接:http://sikaile.net/yixuelunwen/huxijib/2399052.html
最近更新
教材專著